Press Release

CSRXP APPLAUDS REINTRODUCTION OF FAIR DRUG PRICING ACT

Mar 24, 2023

Bipartisan Transparency Legislation Will Help Hold Big Pharma Accountable for Read More

CSRXP: LAWMAKERS MUST HOLD BIG PHARMA ACCOUNTABLE FOR UNCONSCIONABLE PRICE HIKES ON COVID-19 VACCINES AND TREATMENTS

Mar 22, 2023

Senate HELP Committee Hearing with Moderna CEO Offers Prime Opportunity to Read More

CSRXP STATEMENT ON ELI LILLY ANNOUNCEMENT ON PRICE OF INSULIN PRODUCTS

Mar 1, 2023

More Big Pharma Companies Should Also Lower Their Insulin Prices Read More

CSRXP APPLAUDS SENATORS FOR BIPARTISAN ACTION TO HOLD BIG PHARMA ACCOUNTABLE FOR EGREGIOUS PATENT ABUSE

Feb 9, 2023

Senate Judiciary Committee Advances Critical Legislation to Crack Down on Read More

CSRXP APPLAUDS POSITIVE PROGRESS, ENCOURAGES POLICYMAKERS TO ADVANCE ADDITIONAL MARKET-BASED SOLUTIONS TO HOLD BIG PHARMA ACCOUNTABLE

Feb 8, 2023

Policies Must Address Big Pharma’s Egregious Practices That Cause High Drug Read More

CSRXP POLL: VOTERS OVERWHELMINGLY SUPPORT HOLDING BIG PHARMA ACCOUNTABLE TO BUILD ON POSITIVE PROGRESS TOWARD LOWERING RX PRICES

Jan 24, 2023

Broad Majorities Reject Big Pharma’s Blame Game and Want Policymakers to Read More

CSRXP: BIG PHARMA DOUBLES DOWN ON BUSINESS-AS-USUAL AS JANUARY PRICE HIKES CLIMB TO 587

Jan 19, 2023

Brand Name Drug Companies Increase Prices on Treatments for Serious Conditions Read More

CSRXP: MODERNA’S 500 PERCENT VACCINE PRICE HIKE A BRAZEN DEMONSTRATION OF BIG PHARMA’S GREED

Jan 9, 2023

Brand Name Drug Companies Continue Seeking to Price-Gouge COVID-19 Treatments Read More

CSRXP: BIG PHARMA WELCOMES NEW YEAR BY HIKING PRICES ON HUNDREDS OF PRESCRIPTION DRUGS

Jan 3, 2023

Brand Name Drug Companies Maintain Business-as-Usual Approach to Price-Gouging Read More

CSRXP: NEW MOST EXPENSIVE DRUG IN THE WORLD CARRIES PRICE TAG $600,000 HIGHER THAN ESTIMATES FOR A FAIR PRICE

Nov 30, 2022

Hemgenix Pricing Reflects Escalating Big Pharma Trend of Setting Higher and Read More

CSRXP: OUTRAGEOUS PRICE TAG ON NEW DIABETES DRUG LATEST EXAMPLE OF BIG PHARMA’S OUT-OF-CONTROL LAUNCH PRICES

Nov 21, 2022

Drug Company Sets Nearly $200,000 Price on Newly Approved Treatment for Type 1 Read More